Skip to main content
Market intelligence
CRLHealthcare

Charles River Laboratories International Inc. insider activity

In the last 90 days, 1 corporate insider purchased $2,974 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$2,974
Corporate buyers
1
Latest transaction
Oct 5, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 5, 2026Shannon M ParisottoCEVP, Disc & Safety AssessmentSale981$308.44$302,580
Sep 30, 2026Glenn ColemanEVP & Chief Financial OfficerOpen Market Purchase10$297.43$2,974
Aug 25, 2026James C FosterCorporate insiderSale33,561$300.00$10,068,300